Phospho-Bad (Ser112) Antibody

About the Target

The mammalian BAD protein is a member of the BCL-2 family, specifically classified within the BH3-only subgroup. In healthy cells, pro-apoptotic BCL-2 family proteins-including BH3-only proteins like BAD and multidomain proteins such as BAX and BAK-are constitutively expressed. These proteins are typically considered inactive death effectors that require specific activation signals to initiate their pro-apoptotic functions. Depending on the literature source, BAD may also be discussed as Phospho-Bad (Ser112) and Bcl2-associated agonist of cell death.

Reported cellular context includes cytoplasm, membrane, mitochondrion, and mitochondrion outer membrane, which can matter when signal is compared across treatments or changing cell states. Following BAD across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

BAD is commonly interpreted in the context of metabolism, apoptosis, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, membrane, and mitochondrion, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, membrane, and mitochondrion across matched conditions
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring
• separation of survival-associated changes from stress or death-associated readouts
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for BAD. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in BAD reflect biology rather than handling. When interpreting BAD, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep BAD trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.